Agoracom Blog Home

Posts Tagged ‘CSE’

VIDEO – PlantX Life $VEGA.ca $PLTXF Blasts Into 2021 With Plant-Based Expansion In USA, UK, Europe, Israel and #NASDAQ $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 6:03 PM on Wednesday, January 13th, 2021

The paradigm shifting, parabolic growth of plant based foods and a plant based life is unstoppable, with the plant-based food market alone expected to reach $74.2 billion by 2027.

PlantX Life (VEGA:CSE) (PLTXF:OTCQB) Is The One Stop Shop For Everything Plant Based + The  Digital Face of The Plant -Based Community with the following:

  • Plant Based Meal Delivery (20 meals)
  • Plant Based Snack Products
  • Plant Based Pet foods
  • Plant Based Restaurant Locator
  • Plant Based Recipes
  • Plant Based Essentials …. Like Chocolate (Essential?  You Bet)
  • And …… Plant Based …. PLANTS (It’s A BIG Business!)

More than just talk, VEGA is already in full swing and growing FAST

  • Already Operating In Canada
  • US Online Operations Kick Off With $USD 25M MIN of PlantX products YEAR 1
    • 6% Royalty Fee to PlantX on gross USA revenues
  • US Bricks & Mortar with San Diego flagship store opening in DECEMBER
  • £8 million Acquisition of Bloombox In The UK, generating millions in revenue
  • Closed $11.5M Non-Brokered Private Placement
  • · ….. and just announced its Application To List On NASDAQ

If you believe in the massive paradigm shift towards plant based foods and more, be sure to watch and share this great interview with PlantX Life Founder, Sean Dollinger.

You won’t just learn about a great small cap company, you’ll also learn how to live a healthier, tastier life.

Harborside Inc. $HBOR.ca $HBORF Announces Participation in ATB 9th Annual Institutional Investor Conference $VFF.to $HARV.ca $ACB.to

Posted by AGORACOM at 1:46 PM on Wednesday, January 13th, 2021
  • Matt Hawkins, Chairman of Harborside, will participate at the ATB 9th Annual Institutional Investor Conference, January 14, 2021

Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR), (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, announced that Matt Hawkins, Chairman of Harborside, will participate at the ATB 9th Annual Institutional Investor Conference, being held on January 14, 2021. Mr. Hawkins is scheduled to participate in a panel discussion, “U.S. Retail: What Leadership Looks Like Today and Tomorrow”, at 9:40am ET as well as host one-on-one investor meetings throughout the day.

About Harborside:
Harborside Inc. is one of the oldest and most respected cannabis retailers in California, operating three of the major dispensaries in the San Francisco Bay Area, a dispensary in the Palm Springs area outfitted with Southern California’s only cannabis drive-thru window, a dispensary in Oregon and a cultivation/production facility in Salinas, California. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the CSE trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at www.sedar.com.

CLIENT FEATURE: Valeo Pharma $VPH.ca $VPHIF An Innovative Canadian Pharma Company With 9 Products Currently Marketed And 7 Products In Pipeline $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 12:04 PM on Wednesday, January 13th, 2021

(VPH: CSE) (VPHIF: OTCQB) (VP2: FSE)

www.valeopharma.com

Why Valeo Pharma?

  • Commercial stage revenue generating Canadian pharmaceutical company
  • Approaching EBITDA positive in coming months
  • 9 products currently marketed ($40M. estimated peak sales / year)
  • 7 additional products in pipeline ($45M. estimated peak sales / year)
  • In-license business model, no development or clinical risk
  • $1.5M in quarterly revenue ending July 31, 2020
  • $5.26M in revenue for 9 months ending July 31, 2020

What Exactly Does Valeo Pharma Do?

  • Acquires Canadian rights to commercial stage, innovative and proprietary drugs
  • Commercializes innovative prescription products in Canada
  • Focused on Neurodegenerative Diseases,  Oncology and Hospital Specialty Products
  • Internally manages portfolio through all stages of commercialization

Highlights of MDBriefCase Newsletter Comparing Hesperidin and Vitamin C for COVID-19

  • Growing body of research suggests Hesperidin may interfere with SARS-CoV-2 infection process
  • Hesperidin may help against Covid-19 viral replication
  • Hesperidin is a potent antioxidant with anti-inflammatory activity that may help in controlling cytokine storm

Click below to read in its entirety.

Hub On AGORACOM / Corporate Profile

FULL DISCLOSURE: Valeo Pharma is an advertising client of AGORA Internet Relations Corp.

Draganfly $DFLY.ca $DFLYF Begins Process to List on #NASDAQ $FLT.ca $UAVS $ALPP

Posted by AGORACOM-JC at 9:28 AM on Wednesday, January 13th, 2021
  • Announced that the Company has started the process of preparing for a listing of its common shares on the NASDAQ Capital Market
  • Company has engaged a New York based investment bank to begin the NASDAQ listing process.
  • The NASDAQ is a mark of achievement and stature for qualified companies.
  • Listed ‎companies must meet financial and liquidity requirements and satisfy corporate governance and ‎disclosure requirements on both an initial and continuing basis.‎

Los Angeles, CA., Jan. 13, 2021  — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, today announced that the Company has started the process of preparing for a listing of its common shares on the NASDAQ Capital Market (“NASDAQ”).

The Company has engaged a New York based investment bank to begin the NASDAQ listing process. The NASDAQ is a mark of achievement and stature for qualified companies. Listed ‎companies must meet financial and liquidity requirements and satisfy corporate governance and ‎disclosure requirements on both an initial and continuing basis.‎

The listing of the Company’s common shares on the NASDAQ is subject to the approval of the NASDAQ and the ability of the Company to satisfy all applicable listing and regulatory requirements. While the Company intends to satisfy all of the applicable listing criteria, there is no assurance that the NASDAQ will approve the Company’s application or that the Company will complete the listing as proposed.

Draganfly management believes up-listing to NASDAQ will:

  • Provide additional opportunities to attract institutional and retail investors, allowing the Company to broaden its investor base in the United States and internationally.
  • Increase the visibility of the Company, its growth strategy, accomplishments and results to date.
  • Embark on an aggressive M&A strategy.
  • Increase liquidity of the Company’s common shares; and
  • Raise the Company’s overall profile and ultimately enhance shareholder value.

“Today’s announcement is a significant milestone in our efforts to build Draganfly into an industry-leading manufacturer and systems developer,” said Cameron Chell, CEO of Draganfly. “In addition to increasing our visibility in the marketplace, the up-listing should improve the liquidity of our stock, broaden our institutional shareholder base and augment long-term shareholder value.”

Draganfly had significant growth in 2020 in regard to its customer acquisitions, partnerships, product development and the growth of the Company’s sales pipeline. Here are some highlights from the past twelve months:

  • Launched the Vital Intelligence Smart Vital COVID-19 assessment platform that can automatically detect elevated body temperature and, with voluntary consent, heart rate, respiratory rate and O2 saturation, all from a camera that takes seconds to capture the information.
  • Launched a telehealth app for third party developers to integrate the Smart Vital technology with their own apps and devices.
  • Achieved 200%+ year-over-year revenue growth with 50% quarter-over-quarter revenue growth in the third quarter (1) ;
  • Launched two additional flight services divisions in the mining and facility management industries (which includes providing the delivery via Draganfly’s patented drone technologies of the Varigard pathogen and virus surface sanitizer);
  • Exclusive worldwide distributor of Aerovironment’s (NASDAQ: AVAV) Quantix Mapper RPAS;
  • Selected by Coldchain Technology Services, LLC to immediately develop and provide flight services of a robust vaccine delivery payload for use in critical regions for drone delivery of the COVID-19 vaccine; and
  • Awarded new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.

Read More: https://agoracom.com/ir/Draganfly/forums/discussion/topics/752917-draganfly-begins-process-to-list-on-nasdaq/messages/2297567#message

$KABN.ca North America Engages Entoro Capital, LLC as Financial Advisors in the United States of America $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 8:47 AM on Wednesday, January 13th, 2021
kabn-square-new

Financial Service Agreement for US listings, registrations, and potential transactions

  • Announced today that it has retained Houston, Texas based Entoro Capital, LLC , a technology-enabled global investment bank and broker-dealer, to provide a range of Financial Advisory Services in the United States of America.
  • KABN NA and Entoro will together be reviewing KABN NA’s proposed upgraded OTC Markets listing, and in the future, potential, but not assured, U.S. based transactions including, but not limited to a potential Reg A+ offering, registrations, and listing opportunities.
  • Entoro will also use its network to introduce KABN North America to potential business opportunities.

TORONTO, ON and HOUSTON, TX / January 13, 2021 / KABN Systems NA Holdings Corp. (CSE:KABN)(OTC PINK:TRWRF)(FRA:4T51) (the “Company“, “KABN North America” or “KABN NA“) (www.kabnsystemsna.com), a North American Fintech solutions company specializing in empowering individuals to manage, control and generate value from their biometrically-verified Self Sovereign Identity (“SSI”) through its Liquid Avatar (www.liquidavatar.com) platform, announces today that it has retained Houston, Texas based Entoro Capital, LLC (“Entoro”), a technology-enabled global investment bank and broker-dealer, to provide a range of Financial Advisory Services in the United States of America.

KABN NA and Entoro will together be reviewing KABN NA’s proposed upgraded OTC Markets listing, and in the future, potential, but not assured, U.S. based transactions including, but not limited to a potential Reg A+ offering, registrations, and listing opportunities. Entoro will also use its network to introduce KABN North America to potential business opportunities.

Entoro provides advice and services to a wide range of established and growth-oriented businesses around the world. Their experienced professionals offer deep sector expertise across a full range of services in investment banking, equities, and fixed income.

While KABN NA is not proposing any immediate offerings in the US, nor are any assured, Entoro is also a leader in the Regulation A+ capital raise marketplace through its FINRA-registered broker-dealer subsidiary, Entoro Securities, having developed strong retail investor distribution relationships to better leverage the registration exemption for its clients. As part of its service programs, in addition to any traditional offering process, Entoro will be using OfferBoard® to automate any future US-based transactions. OfferBoard® is Entoro’s high-tech, investor portal that provides flexibility, convenience, transparency, and security for investors while increasing engagement and streamlining the entire process. OfferBoard® also allows accredited and qualified investors to review multiple project details and investment criteria with confidence after signing a non-disclosure agreement.

“We have known the world-class investment and management team at Entoro for a number of years and together, we have been looking for the right time and opportunity to work together” said David Lucatch, CEO KABN. “With the open-beta launch of Liquid Avatar just weeks away and having successfully completed our Canadian offerings, in part with Mackie Research this past December, we are excited to bring Entoro on board to help us create awareness, business opportunities, financial advisory services and in the future, potential capital initiatives in the U.S.”

Read More: https://agoracom.com/ir/KABN/forums/discussion/topics/752915-kabn-north-america-engages-entoro-capital-llc-as-financial-advisors-in-the-united-states-of-america/messages/2297560#message

Else Nutrition $BABY.ca $BABYF Receives Canadian Patent for Infant & Toddler Formulation Composition $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 8:07 AM on Wednesday, January 13th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Granted, and registered a Canadian patent (Registration No.: 2,898,980).
  • The patent claims cover the formulation composition for use in an infant and/or toddler formulation.
  • Else, which already holds a worldwide patent covering its 100% plant-based toddler and infant formulas, has just received a grant notice from the Canadian Patent Office on the composition of its proprietary formulation, for use in a non-dairy infant and/or toddler formula.
  • The patented composition provides the necessary proteins, amino-acids and other nutrients needed in a single food serving for a whole balanced nutrition.

VANCOUVER, BC , Jan. 13, 2021  – ELSE NUTRITION HOLDINGS INC. ( BABY.V ) ( BABYF ) ( 0YL.F ) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company , is pleased to update that it has been granted, and registered a Canadian patent (Registration No.:  2,898,980). The patent claims cover the formulation composition for use in an infant and/or toddler formulation.

Else, which already holds a worldwide patent covering its 100% plant-based toddler and infant formulas, has just received a grant notice from the Canadian Patent Office on the composition of its proprietary formulation, for use in a non-dairy infant and/or toddler formula. The patented composition provides the necessary proteins, amino-acids and other nutrients needed in a single food serving for a whole balanced nutrition.

“The growth of our intellectual property portfolio in the Canadian market is timely as we get set to expand our North American presence,” stated Hamutal Yitzhak , CEO and Co-Founder of Else Nutrition. “Our Plant-Based formulation has functional and meaningful applications to a wide range of potential consumer markets. While we remain laser-focused on the launch of our baby products, our IP can also help serve the rapidly growing $3 billion plant-based food market in Canada , giving consumers, nutritious Clean Label, whole food-based offerings,” she added.”

Read more: https://agoracom.com/ir/ElseNutritionHoldings/forums/discussion/topics/752910-else-nutrition-receives-canadian-patent-for-infant-toddler-formulation-composition/messages/2297544#message

Datametrex $DM.ca $DTMXF Announces Strategic Review of Ronin #Blockchain $HUT.ca $BITF.ca $GLXY.ca $HIVE.ca $VYGR.ca

Posted by AGORACOM-JC at 8:00 AM on Wednesday, January 13th, 2021
  • Announced that its wholly owned subsidiary, Ronin Blockchain Corp., a cryptocurrency mining platform, will be revisited by the Company with a view to evaluate various strategic options for the purpose of reactivating the cryptocurrency mining platform to maximize value for the shareholders of the Company.
  • Bitcoin has had a unpresidented run up in value in the last three months from below USD$10,000 to over USD$40,000.
  • This may also include without limitation, a share dividend or an alternative similar transaction.

Toronto, Ontario–(January 13, 2021) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that its wholly owned subsidiary, Ronin Blockchain Corp. (“Ronin”), a cryptocurrency mining platform, will be revisited by the Company with a view to evaluate various strategic options for the purpose of reactivating the cryptocurrency mining platform to maximize value for the shareholders of the Company. This may also include without limitation, a share dividend or an alternative similar transaction.

As part of this strategic review process, Datametrex board and management will collectively review all aspects Ronin to create a strategic plan for the business unit in light of the favourable market conditions which exist for bitcoin and cryptocurrency. Bitcoin has had a unpresidented run up in value in the last three months from below USD$10,000 to over USD$40,000.

According to Forbes[1], a leaked CitiFX report from US banking giant Citibank executive and senior analyst Tom Fitzpatrick has revealed bitcoin could potentially hit a high of $318,000 by December 2021, calling it “21st century gold.” The report was first leaked to the cryptocurrency community by Twitter user “ClassicMacro” in a tweet on November 16, 2020, noting Fitzpatrick is “a big fan of moon targets.”

“With strong run up on Bitcoin, it would prudent for the company and a benefit with our shareholders to complete a full review of Ronin,” said Marshall Gunter, CEO of Datametrex. “Many people within the cryptocurrency space have noted many institutional investors say crypto may be in the middle of a unthinkable rally.”

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/752909-datametrex-announces-strategic-review-of-ronin-blockchain/messages/2297543#message

VIDEO – Isareli-Based Innocan $INNO.ca Global Commercialization Begins. Completes Manufacturing Run In Europe For Premium #CBD Products, Commences Manufacturing For USA Markets $CGC.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 6:29 PM on Tuesday, January 12th, 2021
Innocan-Blog

2020 was a disappointing one for the once euphoric cannabis industry thanks to the fallout of over-hyped and over-financed companies that failed to deliver on a fraction of their promises.  

The year 2000 saw the exact same thing happen to “dot-com” companies that failed in even more spectacular fashion.  Many investors swore off internet stocks forever.  The smart ones waited to see which companies were real … and the rest was history as we saw the birth and growth of internet companies that delivered real value, products and customers.    

The same is about to happen in the Cannabis space in 2021.  With the market estimated to hit $70 Billion over the next few years, there is very little doubt that winners will be created out of companies delivering real businesses  

Enter Innocan Pharma Corporation (INNO:CSE) (IP4: FSE) and it’s incredible team of accomplished scientists led by CEO Iris Bincovich.   

With Distribution and Manufacturing Agreements already in place for Both Europe and USA, $INNO is now on the verge of Commercializing It’s Clinically Proven CBD Products around the world in 2021.

As a Cannabis investor, why limit yourself to a Company with just one specialty, when InnoCan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.  

If you believe in the future of the cannabis industry and companies delivering real, value-add CBD products, then watch this interview with Innocan CEO, Iris Bincovich.

CLIENT FEATURE: Else Nutrition $BABY.ca $BABYF Backed By A $2.7 Billion Global Nutrition Powerhouse $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 4:03 PM on Tuesday, January 12th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Else Nutrition Holdings Inc. (BABY: TSXV) (BABYF: OTCQX) (0YF: FSE) is the award winning, plant-based nutrition company for small cap investors. The shift towards plant-based alternatives has opened the food market to new players, and created an opportunity for fast growth in a rapidly expanding space.  

Highlights include:

  • $CAD 30 Million In Cash
  • Launched 1st Commercial Product Into US Market
  • Backed By A $2.7 Billion Dollar Global Nutrition Company;
  • MOU For International Distribution Of Products
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions
  • Distribution agreement with one of the largest and most well regarded national fresh, organic and specialty food distributors in North America
  • Received key Clean Label Certifications for Toddler Nutrition Product
  • Received Key USDA Organic Certification

Else Expands North American Retail Presence as first Baby Category Product on Plant X – a Leading Plant-Based Ecommerce and Digital Community

Hub On AGORACOM / Corporate Profile

Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.

Draganfly $DFLY.ca $DFLYF Announces Schedule of Live Events at Consumer Electronics Show #CES $FLT.ca $UAVS $ALPP

Posted by AGORACOM-JC at 1:15 PM on Tuesday, January 12th, 2021
  • Draganfly will be featuring its Vital Intelligence system which can enable existing camera systems or cameras on kiosks, drones, tablets and smartphones to measure vital signs as well as its Varigard 24hr pathogen sequestration and kill sanitizing spray applied via patented drones.
  • “We are excited to be exhibiting at CES this year,” said Cameron Chell, CEO of Draganfly. “And we are extremely excited to be holding live events throughout the run of CES.”

Los Angeles, CA, Jan. 12, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce that it has scheduled a series of live events January 13-14 during their participation at the Consumer Electronics Show.

Draganfly will be featuring its Vital Intelligence system which can enable existing camera systems or cameras on kiosks, drones, tablets and smartphones to measure vital signs as well as its Varigard 24hr pathogen sequestration and kill sanitizing spray applied via patented drones.

“We are excited to be exhibiting at CES this year,” said Cameron Chell, CEO of Draganfly. “And we are extremely excited to be holding live events throughout the run of CES.”

All live events are accessible to both participants of CES and external guests.

January 13 1:30PM PST
Live Demo: Draganfly’sVital Intelligence Assessment Technology

Cameron Chell will be joined by Derek Anderson, CEO of Stamina Inc., author,philanthropist, NCAA & NBA Champion, and Jack Chow, Former US Ambassador and Assistant Director-General of the World Health Organization onInfectious Disease and Draganfly Advisor as well as Dr. Javaan Chahl, Defensescience and technology chair at the University of South Australia and ChiefScientist for Draganfly’s Vital Intelligence for a discussion about getting American’sback to work, school and play again. We will also provide a demo of our vitalintelligent technology.
Link to register.

January 14 1130AM PST
Discussion: How to get our athletes back in the game

Join Cameron Chell, CEO of Draganfly in a one-on-one conversation with DerekAnderson NBA, NCAA champion and Draganfly board advisor as they discuss thehot topic of how to make our sports arenas, stadiums and fields safe for the sportsteams, employees, staff and the fans.
Link to register.

January 14 130PM PST
Discussion: Draganfly + Knightscope robots

Draganfly CEO Cameron Chell sits down for a live chat with Knightscope CEOWilliam Santana Li to discuss how Draganfly’s mobile vital sign screening-technology is being used in Knightscope’s autonomous security robots.
Link to register.
Read release: Knightscope has selected to implement Draganfly’s Vital Intelligence technology into its autonomous security robots and embedded applications.